Literature DB >> 20123719

Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis.

Corinne K Cusumano1, Chia S Hung, Swaine L Chen, Scott J Hultgren.   

Abstract

Urinary tract infections (UTIs), the majority of which are caused by uropathogenic Escherichia coli (UPEC), afflict nearly 60% of women within their lifetimes. Studies in mice and humans have revealed that UPEC strains undergo a complex pathogenesis cycle that involves both the formation of intracellular bacterial communities (IBC) and the colonization of extracellular niches. Despite the commonality of the UPEC pathogenesis cycle, no specific urovirulence genetic profile has been determined; this is likely due to the fluid nature of the UPEC genome as the result of horizontal gene transfer and numerous genes of unknown function. UTI89 has a large extrachromosomal element termed pUTI89 with many characteristics of UPEC pathogenicity islands and that likely arose due to horizontal gene transfer. The pUTI89 plasmid has characteristics of both F plasmids and other known virulence plasmids. We sought to determine whether pUTI89 is important for virulence. Both in vitro and in vivo assays were used to examine the function of pUTI89 using plasmid-cured UTI89. No differences were observed between UTI89 and plasmid-cured UTI89 based on growth, type 1 pilus expression, or biofilm formation. However, in a mouse model of UTI, a significant decrease in bacterial invasion, CFU and IBC formation of the pUTI89-cured strain was observed at early time points postinfection compared to the wild type. Through directed deletions of specific operons on pUTI89, the cjr operon was partially implicated in this observed defect. Our findings implicate pUTI89 in the early aspects of infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123719      PMCID: PMC2849428          DOI: 10.1128/IAI.01260-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

1.  TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder.

Authors:  Jeongmin Song; Brian L Bishop; Guojie Li; Matthew J Duncan; Soman N Abraham
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

2.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

3.  Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Cell Microbiol       Date:  2007-05-08       Impact factor: 3.715

Review 4.  Differential gene regulation in Yersinia pestis versus Yersinia pseudotuberculosis: effects of hypoxia and potential role of a plasmid regulator.

Authors:  Guangchun Bai; Eric Smith; Andrey Golubov; Janice Pata; Kathleen A McDonough
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

5.  Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E. coli in a murine urinary tract infection model and a chicken challenge model.

Authors:  Lixiang Zhao; Song Gao; Haixia Huan; Xiaojing Xu; Xiaoping Zhu; Weixia Yang; Qingqing Gao; Xiufan Liu
Journal:  Microbiology       Date:  2009-04-16       Impact factor: 2.777

Review 6.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

7.  Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.

Authors:  Jeffrey P Henderson; Jan R Crowley; Jerome S Pinkner; Jennifer N Walker; Pablo Tsukayama; Walter E Stamm; Thomas M Hooton; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

8.  Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.

Authors:  Danelle S Eto; Tiffani A Jones; Jamie L Sundsbak; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

9.  Detection of intracellular bacterial communities in human urinary tract infection.

Authors:  David A Rosen; Thomas M Hooton; Walter E Stamm; Peter A Humphrey; Scott J Hultgren
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

10.  A comprehensive re-analysis of the Golden Spike data: towards a benchmark for differential expression methods.

Authors:  Richard D Pearson
Journal:  BMC Bioinformatics       Date:  2008-03-26       Impact factor: 3.169

View more
  35 in total

1.  Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Corinne K Cusumano; Thomas J Hannan; James W Janetka; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

4.  Phylogenomic Analysis of Extraintestinal Pathogenic Escherichia coli Sequence Type 1193, an Emerging Multidrug-Resistant Clonal Group.

Authors:  Timothy J Johnson; Ehud Elnekave; Elizabeth A Miller; Jeannette Munoz-Aguayo; Cristian Flores Figueroa; Brian Johnston; Daniel W Nielson; Catherine M Logue; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.

Authors:  Nao Matsuo; Rina Nonogaki; Michiko Hayashi; Jun-Ichi Wachino; Masahiro Suzuki; Yoshichika Arakawa; Kumiko Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

6.  Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Authors:  Drew J Schwartz; Swaine L Chen; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

7.  Establishment and Characterization of UTI and CAUTI in a Mouse Model.

Authors:  Matt S Conover; Ana L Flores-Mireles; Michael E Hibbing; Karen Dodson; Scott J Hultgren
Journal:  J Vis Exp       Date:  2015-06-23       Impact factor: 1.355

Review 8.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

9.  Sex Differences in Population Dynamics during Formation of Kidney Bacterial Communities by Uropathogenic Escherichia coli.

Authors:  Lisa K McLellan; Allyssa L Daugherty; David A Hunstad
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.